Saracatinib, a drug originally developed as a cancer treatment, is now being tested in a phase IIa trial of patients with Alzheimer’s disease after ... More »
Pulse pressure and neurodegeneration in relation to the onset of dementia seem to be associated, according to Daniel A. Nation, Ph.D., and his associa... More »
Cerebrospinal fluid levels of amyloid-beta1-42 and brain amyloid-beta PET imaging with florbetapir-fluorine-18 had a limited association with each oth... More »
Antipsychotics such as haloperidol and risperidone are associated with a significant and dose-related increase in mortality in elderly patients with d... More »
PET scans using radio-labeled flutemetamol were safe to use in vivo and confirmed the presence or absence of neuritic beta-amyloid levels “with high... More »
The Department of Health & Human Services should do more to curb antipsychotic use in older adults with dementia, according to a recent report by ... More »
A public-private Alzheimer’s disease research consortium has christened its open-access research gateway, hoping to speed drug development by sharin... More »
The same dysregulated proteins that form in the brains of patients with Alzheimer’s disease or Parkinson’s disease appear to clump within their sk... More »